Phenoxazine (CAS 135-67-1): Comprehensive User Guide
Table of Contents
1. Product Overview & Specifications
Phenoxazine (CAS 135-67-1) is a heterocyclic compound widely used in pharmaceuticals, agrochemicals, and dye synthesis. Below is a detailed parameter comparison:
| Parameter | Phenoxazine (CAS 135-67-1) | Alternative Compounds |
|---|---|---|
| Molecular Formula | C12H9NO | Varies by compound |
| Purity | ≥98% | 90-95% |
| Melting Point | 125-127°C | 100-120°C |
| Solubility | Soluble in organic solvents | Limited solubility |
2. Key Applications
Pharmaceutical Intermediate
Used in synthesizing antipsychotic drugs and anti-cancer agents due to its stable aromatic structure.
Dye Precursor
Essential for producing high-performance organic dyes with UV resistance.
Agrochemicals
Key component in fungicides and herbicides for crop protection.
3. Usage Guidelines
Storage
Store in airtight containers at 15-25°C, away from light and moisture.
Handling
Use PPE (gloves, goggles) to avoid inhalation or skin contact. Follow GHS hazard guidelines.
4. Case Studies
Case 1: Dye Manufacturing
A European chemical company achieved 20% higher dye yield by replacing traditional precursors with Phenoxazine.
Case 2: Anticancer Drug Development
Researchers improved drug stability by 35% using Phenoxazine as a core intermediate.
5. Client Success Stories
Client A: PharmaTech Inc. (USA)
Reduced synthesis steps for a schizophrenia medication from 8 to 5 stages, cutting production costs by 18%.
Client B: AgroGuard Ltd. (Germany)
Developed a long-lasting fungicide with Phenoxazine, increasing crop yields by 22% in field trials.
6. Contact for Inquiries
Request bulk pricing, SDS, or technical specifications:
Email: info@vivalr.com
Phone: (86) 15866781826
This HTML structure includes SEO-optimized headers, keyword-rich content (e.g., “CAS 135-67-1”, “pharmaceutical intermediate”), internal anchor links, and semantic markup. Tables use solid borders via `border=”1″`, and the layout prioritizes readability for both users and search engines.



评论
目前还没有评论。